Financial Snapshot
Revenues
Revenues
Revenue YoY Change
Revenues
Expenses
Cost Of Revenues
Gross Profit
Gross Profit Margin
Gross Profit
Selling, General & Admin Expense
Research & Development
Depreciation, Depletion & Amortization
SGA Expense to Gross Profit Ratio
R&D To Gross Profit Ratio
DDA To Gross Profit Ratio
Operating Expenses Total
Operating Profits/Loss
Operational Expenses
Interest Expenses
Interest Expenses To Operating Income %
Other Expense/Income
Interest & Other Expense/Income
Income/Loss
Pretax Income
Income Tax
Net Profits/Loss
Pretax Income YoY Change
Income Tax Rate
Net Profits/Loss YoY Change
Basic EPS
Net Income To Revenue Ratio
Pretax & Net Income
Assets & Liabilities
Cash & Short-Term Investments
Cash & Equivalents
Cash To Operating Expenses Ratio
Inventory
Receivables
Total Short-Term Assets
Property, Plant And Equipment
Long-Term Investments
Total Long-Term Assets
Total Assets
Net Income To Total Assets Percentage
Accounts Payable
Short-Term Debt
Long Term Debt Due
Total Short-Term Liabilities
Long-Term Debt
Other Long-Term Liabilities
Total Long-Term Liabilities
Total Liabilities
Short-Term To Long-Term Debt Ratio
Short-Term Assets To Debt Ratio
Long-Term Debt To Net Income Ratio
Assets & Liabilities
Ownership
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares
Stock Issuance & Repurchase
Ownership Data
Return On Shareholders' Equity
Book Value
Free Cash Flow
Free Cash Flow YoY
Free Cash Flow Margin
Dividends
Dividends
Stock Price
About RedHawk Holdings Corp.
RedHawk Holdings Corp. is a holding company, which engages in the distribution and sale of medical devices, sales of branded generic pharmaceutical drugs, commercial real estate investment and leasing, sales of point of entry full-body security systems, specialized financial services, and personal protection equipment. The company is headquartered in Bridgeton, Missouri. The company went IPO on 2011-11-01. The Company, through its subsidiaries, is engaged in sales and distribution of medical devices, sales of branded generic pharmaceutical drugs, commercial real estate investments and leasing, sales of point of entry full-body security system, and specialized financial services. The Company’s segments include Land & Hospitality, Medical Device and Pharmaceutical, and Other Services. Land & Hospitality and Other Services segment operates in the United States. Medical Device and Pharmaceutical segment operate primarily in the United Kingdom. Its land and hospitality business unit consists of commercial and residential property under a long-term lease. The company is engaged in commercial restoration project Grand Naniloa Hotel, in Hawaii. Its medical device and pharmaceutical business unit is engaged in manufacture and sale of Sharps and Needle Destruction Devices and Carotid Artery Digital Non-Contact Thermometer.
Industry: Crude Petroleum & Natural Gas Peers: Fuse Medical, Inc. Cosmos Health Inc. MCKESSON CORP
